| 1 |
34094856 | Losartan protects against osteoarthritis by repressing the TGF-β1 signaling pathway via upregulation of PPARγ. | 2021 Jul |
3 |
| 2 |
30610922 | Losartan attenuates progression of osteoarthritis in the synovial temporomandibular and knee joints of a chondrodysplasia mouse model through inhibition of TGF-β1 signaling pathway. | 2019 Apr |
3 |
| 3 |
31284709 | Transforming Growth Factor β Receptor Type I Inhibitor, Galunisertib, Has No Beneficial Effects on Aneurysmal Pathological Changes in Marfan Mice. | 2019 Jul 9 |
1 |
| 4 |
31611175 | Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα. | 2019 Sep |
1 |
| 5 |
30420805 | Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia. | 2018 |
3 |
| 6 |
27389178 | Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1. | 2017 Jun |
2 |
| 7 |
28323879 | miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling. | 2017 |
1 |
| 8 |
28768908 | Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice. | 2017 Aug 3 |
1 |
| 9 |
26758229 | Suppression for lung metastasis by depletion of collagen I and lysyl oxidase via losartan assisted with paclitaxel-loaded pH-sensitive liposomes in breast cancer. | 2016 Oct |
1 |
| 10 |
26867195 | Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury. | 2016 Feb 8 |
1 |
| 11 |
27501834 | The Combined Use of Losartan and Muscle-Derived Stem Cells Significantly Improves the Functional Recovery of Muscle in a Young Mouse Model of Contusion Injuries. | 2016 Dec |
2 |
| 12 |
25556973 | Angiotensin receptor I stimulates osteoprogenitor proliferation through TGFβ-mediated signaling. | 2015 Jul |
1 |
| 13 |
25766329 | Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A. | 2015 Mar 12 |
2 |
| 14 |
26194911 | Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. | 2015 Sep |
2 |
| 15 |
24355923 | Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. | 2014 Jan |
1 |
| 16 |
22698430 | Novel approach to reduce postsurgical adhesions to a minimum: administration of losartan plus atorvastatin intraperitoneally. | 2013 May 1 |
2 |
| 17 |
23780535 | Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. | 2013 Jun 5 |
1 |
| 18 |
23868934 | Aortic remodeling after transverse aortic constriction in mice is attenuated with AT1 receptor blockade. | 2013 Sep |
1 |
| 19 |
21535912 | Losartan enhances the success of myoblast transplantation. | 2012 |
1 |
| 20 |
22348081 | Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation. | 2012 |
3 |
| 21 |
22479508 | Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition. | 2012 |
1 |
| 22 |
22522482 | Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse. | 2012 May |
5 |
| 23 |
22943509 | Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A). | 2012 Sep 3 |
1 |
| 24 |
21134900 | Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor β1. | 2011 Mar 1 |
1 |
| 25 |
22783312 | Novel pharmacological strategies to prevent aortic complications in Marfan syndrome. | 2011 Dec |
1 |
| 26 |
20112290 | Fibronectin synthesis by high glucose level mediated proliferation of mouse embryonic stem cells: Involvement of ANG II and TGF-beta1. | 2010 May |
1 |
| 27 |
20933212 | TGF-β signaling in aortic aneurysm: another round of controversy. | 2010 Sep |
1 |
| 28 |
21152098 | Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1. | 2010 Nov 30 |
1 |
| 29 |
19635970 | Circulating transforming growth factor-beta in Marfan syndrome. | 2009 Aug 11 |
4 |
| 30 |
18630721 | New insights in the pathogenesis of aortic aneurysms. | 2008 |
1 |
| 31 |
17237794 | Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. | 2007 Feb |
1 |
| 32 |
16601194 | Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. | 2006 Apr 7 |
2 |
| 33 |
15487702 | Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase. | 2004 Summer |
1 |
| 34 |
15496155 | Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells. | 2004 Nov |
1 |
| 35 |
11171784 | Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. | 2001 Feb 13 |
1 |
| 36 |
10840457 | Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis. | 2000 Jul |
1 |